Podcast

The Atomic Show Podcast includes interviews, roundtable discussions and atomic geeks all centered around the idea that nuclear energy is an amazing boon for human society.

Atomic Show #227 – Carmen Bigles, Coqui Radiopharmaceuticals

CarmenBigles-headshot-205x300Coqui Radiopharmaceuticals is a start-up company founded in 2009 with a laser focus on solving a problem affecting the health of tens of thousands of people. The founder, Carmen Bigles, noticed that many of the patients arriving at her clinic had not been properly diagnosed and discovered that the reason for that condition was an insufficient supply of molybdenum-99 to provide technetium-99 for diagnostic nuclear medicine. She recognized that the problem was a solvable one and believed that she had the experience and ability to build a team capable of producing a long term solution.

Ms. Bigles determined that there were proven solutions available, and recognized that the already existing shortage of Mo-99 could not be reliably and promptly solved by starting up a research and development project using novel, unproven ideas.

Her approach to problem solving in this case was to adopt the same solution that had worked for others and to determine the straightest path towards implementing that solution here in the United States.

The path she and her team have chosen is not without risk, but much of the risk in the project comes from regulatory uncertainty and the financial uncertainty that is inherent in a boutique market that has, up until now, been dominated by government-owned, multipurpose facilities that can often afford to sell product at a price that cannot be matched by a private industry.

The perceived regulatory risk can be illustrated with a quote from an article in the November 2014 issue of Nuclear News titled “The Campaign to Resume Domestic Production of Molybdenum.”

Taking on what may be the biggest regulatory challenge is Coqui Pharmaceuticals, a Puerto Rico-based venture that would not only produce reactor-based fission product Mo-99, but would do so in reactors that do not yet exist, and therefore must be permitted and licensed through the NRC.
(Nuclear News, Nov 2014, pg 41)

Despite the doubters, Coqui Radiopharmaceuticals has developed what appears to be a very workable plan, built a strong team, and has engaged consistently with the Nuclear Regulatory Commission.

Just before Ms. Bigles and I spoke, I received a copy of the following press release indicating the achievement of one more milestone on a lengthy, but rewarding journey.


FOR IMMEDIATE RELEASE CONTACT:

Ashley Torres – atorres@krepspr.com
Laura Stace – lstace@krepspr.com
305.663.3543

COQUÍ RADIOPHARMACEUTICALS INKS DEAL WITH INVAP
Nuclear Engineering Firm Chosen as Designer and General Contractor for Florida
Medical Isotope Production Facility

Coral Gables, Fla. (Nov. 20, 2014) — Coquí RadioPharmaceuticals Corp., a medical isotope company working to become the first U.S. commercial producer of Molybdenum-99 (Mo-99), is proud to announce it has formally signed a contract with INVAP to design its Medical Isotope Production Facility (MIPF) in Alachua, Fla. Mo-99 is the parent isotope of Technetium-99, which is used in 80 percent of nuclear medicine procedures worldwide. In 2012, Congress passed legislation making it a national priority to produce Mo-99, an isotope necessary to detect a wide range of diseases, including cardiovascular disease and cancer.

Argentine nuclear engineering firm INVAP has been involved in nuclear development for more than 30 years. During that time it has worked on more than 15 nuclear reactors and related facilities across the world, including several reactors used to produce medical isotopes. Among these is the OPAL reactor in Australia, the ETRR-2 reactor in Egypt, and the NUR reactor in Algeria. Coquí Pharma’s MIPF will use an open pool reactor technology similar to that employed in the INVAP-designed OPAL facility in Australia.

“The signing of this contract cements a key step in implementing proven technology to produce Mo-99 for patients requiring lifesaving medical diagnostics,” said Carmen I. Bigles, Coquí Pharma President and CEO. “Today, Coquí Pharma together with INVAP has built a bridge between the U.S. and Argentina, uniting our efforts to ensure the availability and reliability of the most essential radioisotope in nuclear medicine and with the added benefit of making the world a safer place for generations to come by utilizing proven non-proliferation, low-enriched uranium technologies.”

Coquí Pharma is preparing its construction permit application for submission to the U.S. Nuclear Regulatory Commission. Coquí Pharma will utilize existing commercially proven technology with tested designs to license and build a facility that has the capability of reliably supplying a large portion of the U.S. market and international needs.

Due to recent and future projected shortages, the issue of U.S. domestic medical isotope production has been discussed at great length within the industry and U.S. federal government. Coquí Pharma reviewed options available to manufacture Mo-99 and determined that only the INVAP process provides a real, tangible and reliable solution to solve the medical isotope crisis.

# # #

Coquí RadioPharmaceuticals Corp.

Coquí RadioPharmaceuticals Corp. is a medical isotope company, dedicated to the production of Molybdenum-99, which is used in 20 million procedures each year in the U.S. The Puerto Rican company is based in Coral Gables with the mission to bring the foremost medical isotope production facility in the Western Hemisphere to Alachua, Florida, and to create a commercially scalable, reliable supply of medical diagnostic and therapeutic radioisotopes in the U.S. For more information on Coquí RadioPharmaceuticals, visit www.coquipharma.com.

Play

Atomic Show #226 – Nuclear tour de France reunion

On Wednesday, November 12, I got together with two friends. The three of us were 60% of a group of five writers and bloggers given the opportunity to visit a sampling of nuclear facilities in France owned and operated by Areva. That experience helped form a strong bond. We missed our other two companions from […]

Read more »

Atomic Show #225 – ANS Winter Meeting Leadership Perspectives

The American Nuclear Society Winter Meeting is in progress in Anaheim, CA. I was not able to attend the meeting this year, but I was able to arrange to talk to a couple of people who were there. Guests on this episode of the Atomic Show include Gene Grecheck, the Vice President and incoming President […]

Read more »

Atomic Show #224 – Dr. John Boice NCRP

From front page of June 13, 1956 New York Times. Right column headline.

On November 11, 2014, I had the pleasure of speaking with Dr. John Boice, the President of the National Council on Radiation Protection. Dr. Boice has had a long and distinguished career in radiation protection and is currently leading a multi-decade effort known as the Million Worker Study to investigate the evidence that has been […]

Read more »

Atomic Show #223 – Diablo Saudi UAE Ukraine S Korea

On September 7, 2014, I gathered a group of nuclear energy observers to discuss a variety of topics of interest to people who believe energy is important. We talked about Diablo Canyon’s earthquake resilience, Saudi Arabia’s interest in a rapid growth in nuclear energy production, the certification of the APR+ in South Korea, the progress […]

Read more »

Atomic Show #222 – How Proposed EPA CO2 Rule Rewards States for Replacing Nuclear With Gas

On August 20, 2014, Remy DeVoe, a graduate student in nuclear engineering at the University of Tennessee, published an earthshaking piece on ANS Nuclear Cafe titled Unintended Anti-Nuclear Consequences Lurking in the EPA Clean Power Plan. Unfortunately, there has been a bit of a delayed reaction; so far, only the most carefully tuned instruments have […]

Read more »

Atomic Show #221 – Acting Locally

On August 25, 2014, a group of atomic energy advocates gathered to share experiences and advice about how nuclear energy advocates can more effectively act locally. We discussed ways to find people who are interested in atomic energy, ways to develop social interaction, ways to show our humanity, and ways to make it fun to […]

Read more »

Atomic Show #220 – Atoms for California

Wind farm land impact is not limited to turbine foundation

Andrew Benson from Atoms For California contacted me last week to find out if I was interested in having a conversation about the history of nuclear energy in California, with a special focus on the history of the antinuclear movement in that trend-setting state. It sounded like a great idea for an Atomic Show so […]

Read more »

Atomic Show #219 – Mike Rosen misused Edward Calabrese’s Earth Day column

On Atomic Show #218 – Ed Calabrese – Researching Dose Response Dr. Calabrese shared some important stories about the data manipulations he had discovered relating to the establishment of the linear, no-threshold (LNT) dose response assessment. Those stories will shake the established order. Not surprisingly, two commenters immediately added statements apparently aimed at discrediting Dr. […]

Read more »

Atomic Show #218 – Ed Calabrese – Researching Dose Response

Dr. Ed Calabrese is a professor of toxicology at the University of Massachusetts in Amherst, MA. For the past twenty years, he has focused his research on understanding the response of a variety of organisms and tissues to a variety of chemicals and radiation as doses vary from extremely low to quite high. He is […]

Read more »

Atomic Show #217 – Michael Mariotte, President NIRS

At the suggestion of a long time Atomic Insights contributor and Atomic Show listener, I invited Michael Mariotte for a guest appearance on the Atomic Show. In the small world made up of active nuclear advocates and people adamantly opposed to nuclear energy, Mariotte and his organization are famous — or infamous, depending on one’s […]

Read more »

Atomic Show #216 – Just the Fracks, Ma’am

Greg Kozera is the President of the Virginia Oil and Gas Association and the author of a recently-released book titled Just the Fracks, Ma’am: The Truth About Hydrofracking and the Next Great American Boom. I heard about the book from his publicist, News & Experts. Here is an excerpt from the communication I received. Hi […]

Read more »